Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells

Metabolism: Clinical and Experimental

Volumn 62, Issue 6, 2013, Pages 768-777

  Geng, Shuo ^a,b   Zhou, Shuanhu ^b   Bi, Zhenggang ^a   Glowacki, Julie ^b  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

25 hydroxyvitamin D; Aging; CYP27B1; Osteoblast differentiation

Indexed keywords

COLECALCIFEROL; PARATHYROID HORMONE; VITAMIN D RECEPTOR;

ADIPOCYTE; BONE AGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL STIMULATION; DOWN REGULATION; ENZYME ACTIVITY; GLOMERULUS FILTRATION RATE; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; OSTEOBLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REJUVENATION; REVIEW; UPREGULATION; VITAMIN D METABOLISM;

AGING; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SEPARATION; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOPOROSIS; VITAMIN D;

EID: 84878017202     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.01.003     Document Type: Review

References (85)

1. P.J. Simmons, and B. Torok-Storb Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1 Blood 78 1991 55 62
2. S.A. Kuznetsov, P.H. Krebsbach, and K. Satomura Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo J Bone Miner Res 12 1997 1335 1347
3. M.F. Pittenger, A.M. Mackay, and S.C. Beck Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
4. M. Dezawa, H. Kanno, and M. Hoshino Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation J Clin Invest 113 2004 1701 1710
5. J.M. Luk, P.P. Wang, and C.K. Lee Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models J Immunol Methods 305 2005 39 47
6. J.S. Adams, and M. Hewison Update in vitamin D J Clin Endocrinol Metab 95 2010 471 478
7. P. Liu, B.O. Oyajobi, and R.G. Russell Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) In vitro Calcif Tissue Int 65 1999 173 180
8. S. Zhou, M.S. LeBoff, and J. Glowacki Vitamin D metabolism and action in human bone marrow stromal cells Endocrinology 151 2010 14 22
9. S. Geng, S. Zhou, and J. Glowacki Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1alpha-hydroxylase J Bone Miner Res 26 2011 1145 1153
10. S.M. Mueller, and J. Glowacki Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges J Cell Biochem 82 2001 583 590
11. S. Zhou, E.M. Bueno, and S.W. Kim Effects of age on parathyroid hormone signaling in human marrow stromal cells Aging Cell 10 2011 780 788
12. S. Geng, S. Zhou, and J. Glowacki Age-related decline in osteoblastogenesis and 1alpha-hydroxylase/CYP27B1 in human mesenchymal stem cells: stimulation by parathyroid hormone Aging Cell 10 2011 962 971
13. S. Zhou, J.S. Greenberger, and M.W. Epperly Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts Aging Cell 7 2008 335 343
14. S. Zhou, S. Lechpammer, and J.S. Greenberger Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling J Biol Chem 280 2005 22688 22696
15. L. Shen, J. Glowacki, and S. Zhou Inhibition of adipocytogenesis by canonical WNT signaling in human mesenchymal stem cells Exp Cell Res 317 2011 1796 1803
16. S. Zhou, K. Eid, and J. Glowacki Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells J Bone Miner Res 19 2004 463 470
17. L. Shen, S. Zhou, and J. Glowacki Effects of age and gender on WNT gene expression in human bone marrow stromal cells J Cell Biochem 106 2009 337 343
18. S. Zhou, J. Glowacki, and S.W. Kim Clinical characteristics influence in vitro action of 1,25-dihydroxyvitamin D(3) in human marrow stromal cells J Bone Miner Res 27 2012 1992 2000
19. M. Al-Nbaheen, R. Vishnubalaji, and D. Ali Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential Stem Cell Rev 2012 [Epub ahead of print]
20. P. Anklesaria, J. Teixido, and M. Laiho Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation Proc Natl Acad Sci U S A 87 1990 3289 3293
21. M.A. Sakakeeny, and J.S. Greenberger Granulopoiesis longevity in continuous bone marrow cultures and factor-dependent cell line generation: significant variation among 28 inbred mouse strains and outbred stocks J Natl Cancer Inst 68 1982 305 317
22. A.J. Friedenstein, K.V. Petrakova, and A.I. Kurolesova Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues Transplantation 6 1968 230 247
23. I. Bab, B.A. Ashton, and D. Gazit Kinetics and differentiation of marrow stromal cells in diffusion chambers in vivo J Cell Sci 84 1986 139 151
24. G. D'Ippolito, P.C. Schiller, and C. Ricordi Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow J Bone Miner Res 14 1999 1115 1122
25. K. Harigaya, and H. Handa Generation of functional clonal cell lines from human bone marrow stroma Proc Natl Acad Sci U S A 82 1985 3477 3480
26. C.M. Gordon, M.S. LeBoff, and J. Glowacki Adrenal and gonadal steroids inhibit IL-6 secretion by human marrow cells Cytokine 16 2001 178 186
27. D. Cheleuitte, S. Mizuno, and J. Glowacki In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status J Clin Endocrinol Metab 83 1998 2043 2051
28. Y. Chang, P.H. Hsieh, and C.C. Chao The efficiency of Percoll and Ficoll density gradient media in the isolation of marrow derived human mesenchymal stem cells with osteogenic potential Chang Gung Med J 32 2009 264 275
29. P. Kasten, I. Beyen, and M. Egermann Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro Eur Cell Mater 16 2008 47 55
30. S. Gronthos, S.E. Graves, and S. Ohta The STRO-1 + fraction of adult human bone marrow contains the osteogenic precursors Blood 84 1994 4164 4173
31. S. Gronthos, A.C. Zannettino, and S.J. Hay Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow J Cell Sci 116 2003 1827 1835
32. N. Quirici, D. Soligo, and P. Bossolasco Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies Exp Hematol 30 2002 783 791
33. E.J. Gang, D. Bosnakovski, and C.A. Figueiredo SSEA-4 identifies mesenchymal stem cells from bone marrow Blood 109 2007 1743 1751
34. K. Mrozik, S. Gronthos, and S. Shi A method to isolate, purify, and characterize human periodontal ligament stem cells Methods Mol Biol 666 2010 269 284
35. W. Wagner, F. Wein, and A. Seckinger Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood Exp Hematol 33 2005 1402 1416
36. S. Christakos, P. Dhawan, and Y. Liu New insights into the mechanisms of vitamin D action J Cell Biochem 88 2003 695 705
37. J.L. Omdahl, and B.K. May The 25-hydroxyvitamin D 24-hydroxylase D. Feldman, F.H. Glorieux, J.W. Pike, Vitamin D 1997 San Diego Academic Press 69 85
38. M. Schuessler, N. Astecker, and G. Herzig Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)-hydroxylases Steroids 66 2001 399 408
39. M. van Driel, M. Koedam, and C.J. Buurman Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells FASEB J 20 2006 2417 2419
40. D. Zehnder, and M. Hewison The renal function of 25-hydroxyvitamin D3-1alpha-hydroxylase Mol Cell Endocrinol 151 1999 213 220
41. G.A. Howard, R.T. Turner, and D.J. Sherrard Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 J Biol Chem 256 1981 7738 7740
42. M. Kogawa, D.M. Findlay, and P.H. Anderson Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption Endocrinology 151 2010 4613 4625
43. M. Kogawa, P.H. Anderson, and D.M. Findlay The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts J Steroid Biochem Mol Biol 121 2010 277 280
44. G.J. Atkins, P.H. Anderson, and D.M. Findlay Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3 Bone 40 2007 1517 1528
45. P.H. Anderson, G.J. Atkins, and D.M. Findlay RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells J Steroid Biochem Mol Biol 103 2007 601 605
46. D.D. Bikle, S. Chang, and D. Crumrine 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis J Invest Dermatol 122 2004 984 992
47. S. Pillai, D.D. Bikle, and P.M. Elias 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation J Biol Chem 263 1988 5390 5395
48. J.Y. Hsu, D. Feldman, and J.E. McNeal Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition Cancer Res 61 2001 2852 2856
49. D. Zehnder, R. Bland, and M.C. Williams Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase J Clin Endocrinol Metab 86 2001 888 894
50. M. Hewison, L. Freeman, and S.V. Hughes Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells J Immunol 170 2003 5382 5390
51. J.S. Adams, T.G. Beeker, and T. Hongo Constitutive expression of a vitamin D 1-hydroxylase in a myelomonocytic cell line: a model for studying 1,25-dihydroxyvitamin D production in vitro J Bone Miner Res 5 1990 1265 1269
52. J.S. Adams, F.R. Singer, and M.A. Gacad Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis J Clin Endocrinol Metab 60 1985 960 966
53. V. Lagishetty, R.F. Chun, and N.Q. Liu 1alpha-hydroxylase and innate immune responses to 25-hydroxyvitamin D in colonic cell lines J Steroid Biochem Mol Biol 121 2010 228 233
54. J. Li, M.E. Byrne, and E. Chang 1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes J Steroid Biochem Mol Biol 112 2008 122 126
55. D. Zehnder, R. Bland, and R.S. Chana Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion J Am Soc Nephrol 13 2002 621 629
56. U. Segersten, P. Correa, and M. Hewison 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands J Clin Endocrinol Metab 87 2002 2967 2972
57. U. Segersten, P.K. Holm, and P. Bjorklund 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha- hydroxylated vitamin D analogue Breast Cancer Res 7 2005 R980 R986
58. K.N. Evans, H. Taylor, and D. Zehnder Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy Am J Pathol 165 2004 807 813
59. E. Avila, L. Diaz, and A. Halhali Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase, 1,25-dihydroxyvitamin D3 24-hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells J Steroid Biochem Mol Biol 89-90 2004 115 119
60. D. Somjen, Y. Weisman, and F. Kohen 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds Circulation 111 2005 1666 1671
61. M. Davies, M.E. Hayes, and J.A. Yin Abnormal synthesis of 1,25-dihydroxyvitamin D in patients with malignant lymphoma J Clin Endocrinol Metab 78 1994 1202 1207
62. E.B. Mawer, M.E. Hayes, and S.E. Heys Constitutive synthesis of 1,25-dihydroxyvitamin D3 by a human small cell lung cancer cell line J Clin Endocrinol Metab 79 1994 554 560
63. D.D. Bikle, M.K. Nemanic, and E. Gee 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation J Clin Invest 78 1986 557 566
64. K. Satomura, Y. Seino, and K. Yamaoka Renal 25-hydroxyvitamin D3-1-hydroxylase in patients with renal disease Kidney Int 34 1988 712 716
65. A. Stolzing, and A. Scutt Age-related impairment of mesenchymal progenitor cell function Aging Cell 5 2006 213 224
66. M. Ishida, B. Bulos, and S. Takamoto Hydroxylation of 25-hydroxyvitamin D3 by renal mitochondria from rats of different ages Endocrinology 121 1987 443 448
67. H.L. Brenza, and H.F. DeLuca Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3 Arch Biochem Biophys 381 2000 143 152
68. M.R. Haussler, D.J. Baylink, and M.R. Hughes The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels Clin Endocrinol (Oxf) 5 Suppl 1976 151S 165S
69. R.M. Neer, C.D. Arnaud, and J.R. Zanchetta Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 2001 1434 1441
70. R.L. Jilka, R.S. Weinstein, and T. Bellido Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone J Clin Invest 104 1999 439 446
71. T.L. McCarthy, M. Centrella, and E. Canalis Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone Endocrinology 124 1989 1247 1253
72. Y. Wang, S. Nishida, and B.M. Boudignon IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone J Bone Miner Res 22 2007 1329 1337
73. S. Zhou, S. Geng, and J. Glowacki Histone deacetylation mediates the rejuvenation of osteoblastogenesis by the combination of 25(OH)D3 and parathyroid hormone in MSCs from elders J Steroid Biochem Mol Biol 2012 doi:pii: S0960-0760(12)00158-6. 10.1016/j.jsbmb.2012.09.002. [Epub ahead of print]
74. P.-L. Chung, S. Zhou, B. Eslami, L. Shen, M.S. LeBoff, and J. Glowacki Effect of age on regulation of human osteoclast differentiation J Orthop Res 2013 In press.
75. B. Dawson-Hughes, A. Mithal, and J.P. Bonjour IOF position statement: vitamin D recommendations for older adults Osteoporos Int 21 2010 1151 1154
76. Institute of Medicine Dietary reference intakes for calcium and vitamin D 2011 The National Academies Press Washington, DC
77. M.F. Holick, E.S. Siris, and N. Binkley Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy J Clin Endocrinol Metab 90 2005 3215 3224
78. R.N. Moorthi, P. Kandula, and S.M. Moe Optimal vitamin D, calcitriol, and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question Curr Opin Nephrol Hypertens 20 2011 354 359
79. S. Zhou, M.S. LeBoff, S.S. Waikar, and J. Glowacki Vitamin D metabolism and action in human marrow stromal cells: effects of chronic kidney disease J Steroid Biochem Mol Biol 2012 doi:pii: S0960-0760(12)00165-3. 10.1016/j.jsbmb.2012.09.009. [Epub ahead of print]
80. R. Samadfam, Q. Xia, and D. Miao Exogenous PTH and endogenous 1,25-dihydroxyvitamin D are complementary in inducing an anabolic effect on bone J Bone Miner Res 23 2008 1257 1266
81. D.E. Sellmeyer, D.M. Black, and L. Palermo Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis Osteoporos Int 18 2007 973 979
82. B. Dawson-Hughes, P. Chen, and J.H. Krege Response to teriparatide in patients with baseline 25-hydroxyvitamin D insufficiency or sufficiency J Clin Endocrinol Metab 92 2007 4630 4636
83. F. Cosman, B. Dawson-Hughes, and X. Wan Changes in vitamin D metabolites during teriparatide treatment Bone 50 2012 1368 1371
84. S. Boonen, F. Marin, and D. Mellstrom Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective J Am Geriatr Soc 54 2006 782 789
85. P. Schwarz, N.R. Jorgensen, and L. Mosekilde Effects of increasing age, dosage, and duration of PTH treatment on BMD increase - a meta-analysis Calcif Tissue Int 90 2012 165 173